Industry Reports
-
Promoting an overdue digital transformation in healthcare
2019-06-15
For all the ways that technology is transforming the way people shop, bank, and travel, it has yet to make major inroads into how they receive healthcare. The adoption of digitally enabled tools for diagnosis, treatment, and management, for example, has been modest. Electronic medical records are still not a part of routine care. According to the Electronic Medical Record Adoption model, adoption ranges from just 3 percent in Europe to 35 percent in the United States....
>>
-
Accenture: 2019 Digital Health Trends Report
2019-06-07
To better understand the huge opportunities that digital health solutions present for California, Accenture and the California Life Sciences Association (CLSA), the trade association representing California’s life sciences sector, have conducted the state’s fi rst-ever study on digital health amongst life sciences companies. Executives from 184 biopharmaceutical, medical device and technology companies, with revenues exceeding $10 million, participated in our industry-wide survey. Additionally, we conducted 25 interviews with C-level life science thought leaders to get an inside look at the innovation going on in the digital health space....
>>
-
Accenture: Digital Health Tech Vision 2019
2019-06-04
It has become part of everything we do as people, as businesses and society. However, its impact on the expectations of individual people is changing. People are increasingly expecting healthcare on their own terms, and they expect digital to be the enabler....
>>
-
Mckinsey: The era of exponential improvement in healthcare?
2019-05-20
Healthcare advances have delivered great benefits to society, bringing material improvements in average life spans and quality of life. Yet these improvements have come at a cost—an ever-expanding portion of the US GDP is being consumed by healthcare expenses....
>>
-
Global Healthcare Private Equity and Corporate M&A Report 2020
2019-05-04
The disclosed value of healthcare corporate M&A rose by 25% in 2019, to a new high of $541 billion. Two megamergers—namely, Bristol-Myers Squib acquired Celgene, and AbbVie bought Allergan—totaled $182 billion. We expect brisk deal activity to continue in the near future as public healthcare companies use acquisitions to grow revenue, which public markets continue to reward differentially relative to profit margin expansion. New Bain & Company analysis of S&P Capital IQ data shows that revenue growth accounts for 62% of total shareholder returns over the past five years, a far more important factor than profit margin expansion, which accounts for only 9%....
>>
-
Deloitte: The future of Life Sciences and Health Care in Asia Pacific
2019-05-04
Given that quality, outcomes, and value are the new buzzwords for the Life Sciences and Health Care industry, stakeholders around the globe are looking for innovative, cost-effective ways to deliver patient-centric, technology-enabled solutions to patients both inside and outside hospital walls....
>>
-
Deloitte: 2020 Global life sciences outlook
2019-04-30
Gene therapies, intelligent drug discovery and development, consumer wearables, telemedicine, and more—what are some of the drivers transforming the life sciences sector? How can biopharma and medtech organizations create new value in 2020, while tackling various challenges? What are the metrics that matter?...
>>
-
Deloitte: Return on capital performance in life sciences and health care
2019-04-30
With more change in store for the future, we look at where opportunities for consolidation and convergence lie for each health care sector, using return on capital employed as a measure of success or value delivered....
>>
